NACD Board Leadership Conference NACD Chapter System NACDonline.org
Print This Page

Seattle I The Board's Role in Long-term Value Creation

Classroom
March 21, 2017
Seattle, WA



Member Price: $45
Non-Member Price: $60

Overview

 

We’re privileged to have Ray Gilmartin, who has served as Chairman and CEO of Merck, on the boards of Microsoft and General Mills, and as Harvard Business School faculty, lead this program which explores the need for a new level of strategic board engagement in today’s competitive and innovative business environment. Discussion will include how your board can hold management accountable for short-term results without allowing a “meet or beat the quarter” mentality to undermine or dilute the company’s focus on long-term strategic objectives.
This customized program will be of value to:

  • Boards of every type that are focused on helping management maintain a direct connection between short-term viability and long-term value creation
  • Board leaders who want a deeper understanding of how directors can take a more active role in the alignment of short- and long-term strategy by applying their unique perspectives and skills

Come prepared for a highly interactive session with audience participation encouraged where you can share and discuss your experiences and/or thoughts on the topic.  A complimentary copy of NACD’s Blue Ribbon Commission report on “The Board and Long-Term Value Creation” will be provided.

Location and Time

 

Washington Athletic Club
1325 6th Avenue
Seattle, WA 98101

7:00 am - 7:30 am: Networking Breakfast

7:30 am - 9:00 am: Program



Speaker Spotlight

 

Ray Gilmartin

Raymond V. Gilmartin is the former Chairman, President and Chief Executive Officer of Merck & Co., Inc., a global research driven pharmaceutical company that discovers, develops, manufactures and markets innovative vaccines and medicines. Mr. Gilmartin joined Merck as President and Chief Executive Officer in June 1994 and was named to the additional position of Chairman of the Board in November 1994. Shortly after retiring from Merck in 2006, he joined the faculty at Harvard Business School where he taught in the MBA and executive education programs through 2012. Prior to joining Merck, Mr. Gilmartin served as Chairman, President and CEO of Becton Dickinson, a global company that develops, manufactures and markets medical devices and diagnostic products. He joined that company in 1976 as vice president, strategic planning, and took on positions of increasing responsibility over the next eighteen years. Mr. Gilmartin is on the board of the National Association of Corporate Directors. He has served as the Lead Director for Microsoft and General Mills. He is a trustee of the Committee for Economic Development. He is the past Chairman of the Board of The United Negro College Fund and has served as Chairman of the Board of Dean's Advisors for the Harvard Business School. Mr. Gilmartin has been an active participant in health industry affairs worldwide. Mr. Gilmartin was co-chair of the Presidential Advisory Council on HIV/AIDS, is a past chair of the Healthcare Leadership Council and was a board member of the Alliance for Healthcare Reform. In addition, he is the past chair of the Pharmaceutical Research and Manufacturers of America and a past president of the International Federation of the Pharmaceutical Manufacturers Associations. Mr. Gilmartin also has been involved in global economic and trade issues that concern the pharmaceutical industry. He was a member of the President's Export Council and is a past chair of the Council on Competitiveness.

Accreditation

 




Question about this Event?

Contact Northwest Chapter 24 Roy Street, PMB 24, Seattle, WA, 98109 phone: 206-524-5300 fax: 206-299-9098 email: programs@northwest.nacdonline.org